Active substances
Ethinylestradiol + Levonorgestrel
- SFDA 5
- US FDA 84
- Health Canada 21
- US price lines 18
- NHS prices 1
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LOGYNON TAB | 30,125 µg,µg | Tablet · Oral use | 21 Blister | SAR 12.10 | NCE · Prescription | BAYER AG | Valid |
| MICROGYNON-30 21TAB | 30,150 µg | Tablet · Oral use | 21 Blister | SAR 11.45 | Generic · Prescription | BAYER SCHERING PHARMA | Withdrawn by MAH · Not Marketed |
| NEOGYNON TAB | 0.050, 0.25 mg | Tablet · Oral use | 21 Blister | SAR 11.45 | Generic · Prescription | BAYER SCHERING PHARMA | Withdrawn by MAH · Not Marketed |
| NORDETTE 21TAB | 0.03, 0.15 mg | Tablet · Oral use | 21 Blister | SAR 11.45 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
| NORDIOL 21TAB | 50, 0.25 µg | Tablet · Oral use | 21 Blister | SAR 11.45 | Generic · Prescription | WYETH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
CONTRACEPTION; ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| LEVORA 0.15/30-28 | 0.03MG;0.15MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 13 Dec 1993 |
| TRIVORA-28 | 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 18 Dec 1997 |
| AVIANE-28 | 0.02MG;0.1MG | tablet · oral-28 | DURAMED PHARMS BARR | Prescription | 30 Apr 2001 |
| ENPRESSE-28 | 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG | tablet · oral-28 | DURAMED PHARMS BARR | Prescription | 16 Jul 2001 |
| LESSINA-28 | 0.02MG;0.1MG | tablet · oral-28 | BARR | Prescription | 20 Mar 2002 |
| PORTIA-28 | 0.03MG;0.15MG | tablet · oral-28 | BARR | Prescription | 23 May 2002 |
| SEASONALE | 0.03MG;0.15MG | tablet · oral | TEVA BRANDED PHARM | Prescription | 5 Sep 2003 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 18 Nov 2004 |
| SEASONIQUE | 0.03MG,0.01MG;0.15MG,N/A | tablet · oral | TEVA BRANDED PHARM | Prescription | 25 May 2006 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 31 May 2006 |
| QUASENSE | 0.03MG;0.15MG | tablet · oral | WATSON LABS | Prescription | 6 Sep 2006 |
| LOSEASONIQUE | 0.02MG,0.1MG;0.01MG,N/A | tablet · oral | TEVA BRANDED PHARM | Prescription | 24 Oct 2008 |
| ALTAVERA | 0.03MG;0.15MG | tablet · oral-28 | XIROMED | Prescription | 3 Aug 2010 |
| INTROVALE | 0.03MG;0.15MG | tablet · oral | XIROMED | Prescription | 27 Sep 2010 |
| LEVONEST | 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG | tablet · oral-28 | NOVAST LABS LTD | Prescription | 29 Dec 2010 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 0.03MG,0.01MG;0.15MG,N/A | tablet · oral | DR REDDYS LABS SA | Prescription | 31 May 2011 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.09MG | tablet · oral | WATSON LABS | Prescription | 6 Jun 2011 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL | 0.02MG,0.1MG;0.01MG,N/A | tablet · oral | LUPIN LTD | Prescription | 26 Oct 2011 |
| MARLISSA | 0.03MG;0.15MG | tablet · oral-28 | GLENMARK PHARMS LTD | Prescription | 29 Feb 2012 |
| FALMINA | 0.02MG;0.1MG | tablet · oral-28 | NOVAST LABS LTD | Prescription | 28 Mar 2012 |
| KURVELO | 0.03MG;0.15MG | tablet · oral-28 | LUPIN LTD | Prescription | 17 Oct 2012 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.03MG;0.15MG | tablet · oral | LUPIN LTD | Prescription | 23 Oct 2012 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.03MG;0.15MG | tablet · oral-28 | XIROMED | Prescription | 21 Dec 2012 |
| LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | tablet · oral-28 | LUPIN LTD | Prescription | 18 Jan 2013 |
| QUARTETTE | 0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A | tablet · oral | TEVA BRANDED PHARM | Prescription | 28 Mar 2013 |
59 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ALESSE 21 | 02236974 | 100 MCG; 20 MCG | TABLET · ORAL | PFIZER CANADA ULC |
| ALESSE 28 | 02236975 | 20 MCG; 100 MCG | TABLET · ORAL | PFIZER CANADA ULC |
| ALYSENA 21 | 02387875 | 100 MCG; 20 MCG | TABLET · ORAL | APOTEX INC |
| ALYSENA 28 | 02387883 | 20 MCG; 100 MCG | TABLET · ORAL | APOTEX INC |
| AUDRINA 21 | 02532174 | 20 MCG; 100 MCG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| AUDRINA 28 | 02532182 | 20 MCG; 100 MCG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| AVIANE 21 | 02298538 | 20 MCG; 100 MCG | TABLET · ORAL | TEVA CANADA LIMITED |
| AVIANE 28 | 02298546 | 100 MCG; 20 MCG | TABLET · ORAL | TEVA CANADA LIMITED |
| INDAYO | 02398869 | 0.15 MG; 0.03 MG | TABLET · ORAL | SENADOR LABORATORIES PRIVATE LIMITED |
| LAYLAA 21 | 02424282 | 100 MCG; 20 MCG | TABLET · ORAL | LUPIN PHARMA CANADA LIMITED |
| LAYLAA 28 | 02424290 | 20 MCG; 100 MCG | TABLET · ORAL | LUPIN PHARMA CANADA LIMITED |
| MIN-OVRAL 21 | 02042320 | 30 MCG; 150 MCG | TABLET · ORAL | PFIZER CANADA ULC |
| MIN-OVRAL 28 | 02042339 | 150 MCG; 30 MCG | TABLET · ORAL | PFIZER CANADA ULC |
| OVIMA 21 | 02387085 | 30 MCG; 150 MCG | TABLET · ORAL | APOTEX INC |
| OVIMA 28 | 02387093 | 30 MCG; 150 MCG | TABLET · ORAL | APOTEX INC |
| PORTIA 21 | 02295946 | 0.03 MG; 0.15 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| PORTIA 28 | 02295954 | 0.15 MG; 0.03 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| SEASONALE | 02296659 | 0.15 MG; 0.03 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| SEASONIQUE | 02346176 | 0.15 MG; 0.01 MG; 0.03 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| TRIQUILAR 21 | 00707600 | 40 MCG; 125 MCG; 30 MCG; 50 MCG; 75 MCG | TABLET · ORAL | BAYER INC |
| TRIQUILAR 28 | 00707503 | 50 MCG; 30 MCG; 125 MCG; 40 MCG; 75 MCG | TABLET · ORAL | BAYER INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ALTAVERA-28 TABLET | $0.11352 | per EA | 23 Sep 2026 |
| US NADAC | ASHLYNA 0.15-0.03-0.01 MG TAB | $0.12477 | per EA | 23 Sep 2026 |
| US NADAC | AYUNA-28 TABLET | $0.11352 | per EA | 23 Sep 2026 |
| US NADAC | BALCOLTRA TABLET | $10.03814 | per EA | 1 Jan 2026 |
| US NADAC | DAYSEE 0.15-0.03-0.01 MG TAB | $0.12477 | per EA | 23 Sep 2026 |
| US NADAC | DOLISHALE 90-20 MCG TABLET | $1.13572 | per EA | 23 Sep 2026 |
| US NADAC | FALMINA-28 TABLET | $0.15354 | per EA | 23 Sep 2026 |
| US NADAC | INTROVALE 0.15-0.03 MG TABLET | $0.22674 | per EA | 23 Sep 2026 |
| US NADAC | JAIMIESS 0.15-0.03-0.01 MG TAB | $0.12477 | per EA | 23 Sep 2026 |
| US NADAC | KURVELO-28 TABLET | $0.11352 | per EA | 23 Sep 2026 |
| US NADAC | LEVONEST-28 TABLET | $0.32363 | per EA | 23 Sep 2026 |
| US NADAC | MARLISSA-28 TABLET | $0.11352 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Ethinylestradiol 30microgram / Levonorgestrel 150microgram tablets | £2.82 | 63 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 22.1.1. Oral hormonal contraceptives · core
Contact with health services for contraceptive management
Oral > Solid: 30 µg + 150 µg
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.